This podcast is archived and some details may be out of date.

<p>You need to be an existing investor of this {{FundOrStrategy}} before you can view its details.</p>
<p>If you are not an existing investor of this {{FundOrStrategy}}, please close this message and you'll be directed to our list of funds.</p>

If none of the previous options apply, please select Rest of World below:

I invest on my own behalf, am a job seeker, a journalist or want to learn more about Baillie Gifford.

Individual investor

Professional Investors

Non-UK Shareholders

Non-UK

SELECT LOCATION

This article is archived and some details may be out of date.

Home

This private website has been shared on a reverse solicitation basis only. It is intended to only be accessed by the recipient: a professional or institutional investor who has received the direct link from Baillie Gifford following a reverse enquiry. It has been designed to provide you with the specific information you have requested from Baillie Gifford. It is not for onward distribution, and is not intended for use with retail clients.

Legal declaration

This video is archived and some details may be out of date.

Philosophy

Deliberately different in more ways than one. Discover our investment philosophy and learn how we differentiate ourselves from the rest.

Performance

Insights

Podcast

Documents

You are viewing the site as Insights in Non-UK

About Us

Frequently Asked Questions

Email Sign Up

From vaccine provider to potential cancer preventer, mRNA’s many possible uses set Moderna apart.

Moderna: from Covid vaccines to cancer cures

Share

Speakers

Overview

https://media.bailliegifford.com/mws/0f1hspg3/transcript-moderna-from-covid-vaccines-to-cancer-cures-invest-in-progress-jan-2024.pdf

Moderna: from Covid vaccines to cancer cures

Related insights

Perspectives on Progress #11

Portfolio Update

Perspectives on progress #10

Perspectives on Progress #9